2019

ISO22000:2018 certification (Health Food Plant)

2018

ISO13485:2016 certification

2016

ISO13485:2003 certification

2014

Set up a joint venture with Taiwan Industrial Technology Research Institute (ITRI) to develop a new botanical drug that helps the human body to repair cardiac muscle cells

2013

Passed PIC/S GMP audit by TFDA (Taoyuan Master Plant)

2011

• First approved by Japan PMDA audit (Kuan Yin Plant)
• First approved by US FDA audit (Taoyuan Master Plant)

2010

• Approved by Korea FDA audit (Taoyuan Master Plant)
• Passed PIC/S GMP audit by TFDA (Kuan Yin Plant)

2009

Approved by Belarus FDA audit (Taoyuan Master Plant)

2008

First approved by Japan PMDA audit (Taoyuan Master Plant)

2007

API, Bisoprolol Fumarate, filed in U.S. DMF

2006

• Taoyuan Master Plant and Kuan Yin plant got Accreditation of Foreign Drug Manufacturer (sterile and non-sterile products) from MHLW Japan
• Veterans Pharmaceutical Plant acquired

2005

Kuan Yin Plant acquired from Fujisawa Pharmaceutical

2003

Beijing Sintong Biotech Co, Ltd established in China

2002

Health Food plant at Hsinchu established

2001

Renamed as Taiwan Biotech Co, Ltd

1999

Established US subsidiary, Optics Lab, and started exporting eye care products to the US market

1997

Started exporting 20ml BFS injectables to Japan

1996

Launched Anpo (Ritodrine) in China

1995

Launched innovative transdermal nicotine patch

1992

Invested in Huaneng Pharmaceutical Inc. in China

1990

Joint development of TDDS patch with an U.S. pharmaceutical development company

1987

• Passed GMP inspection in Taiwan
• Exported vitamin injection to Vietnam, and began global expansion

1979

First BFS (Blow-Fill-Seal) machine installed

1962

Company reorganized as Sintong Chemical

1945

Company predecessor, Glucose Corporation, established